Studies
VX21-147-301, VX-147, for APOL1
Internal Medicine
Nephrology
Kidney Disease
Pediatric Subjects
Adult Subjects
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney disease.